使用可解释的机器学习预测成年性休克患者对固定剂量甲基蓝的反应性:一项回顾性研究
Shasha Xue1, Li Li2,3, Zhuolun Liu1
1School of Computer Science and Engineering, Central South University, Changsha, 410083, China.
Scientific reports
|February 28, 2025
概括
这项研究开发了一种可解释的机器学习模型,用于预测败血症休克患者的甲基蓝 (MB) 反应能力. 较高剂量的北上腺素等效和升高的乳酸盐水平是MB反应的关键预测因素.
科学领域:
- 临界护理医学 临界护理医学
- 医疗保健中的机器学习
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐火性败血性休克带来了重大的临床挑战,通常需要血管压缩剂支持.
- 甲蓝 (MB) 用于治疗耐火性败血症,但很难预测患者的反应.
- 需要可解释的模型来指导MB治疗决策.
研究的目的:
- 开发和验证可解释的机器学习模型,用于预测耐火性败血性休克的成年患者的MB响应能力.
- 为了确定影响MB响应性的关键临床因素,使用SHapley添加式扩展 (SHAP).
主要方法:
- 对416名耐火性败血症休克患者的回顾性分析,这些患者接受了MB治疗.
- 使用统计和机器学习特征选择开发预测模型 (逻辑回归,SVM,随机森林,LightGBM,EBM).
- 评估模型的歧视,校准和临床实用性,包括外部验证.
- 应用SHAP分析来识别重要的预测特征.
主要成果:
- 支持矢量机 (SVM) 模型实现了0.74 (内部) 和0.75 (外部验证) 的AUC,准确度为76%.
- SHAP分析确定了平均上腺素等效剂量 (NEE) 和乳酸水平作为MB响应性的最重要的预测指标.
- 在MB给药之前,较高的NEE剂量与更高的响应概率相关.
结论:
- 一个可解释的机器学习模型,特别是SVM,可以有效地预测耐火性败血症休克的MB响应能力.
- 上腺素等效剂量和乳酸水平是影响MB治疗结果的关键因素.
- 这种模型在优化MB疗法对败血症休克患者的潜在临床实用性.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...